✦ LIBER ✦

413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3

✍ Scribed by T. Poynard; E.R. Schiff; R. Terg; R. Moreno-Otero; S.L. Flamm; W. Schmidt; T. Berg; F.L. Goncales; J.E. Heathcote; M. Diago; T. McGarrity; P. Bedossa; H. Zhou; P. Mukhopadhyay; L.H. Griffel; M. Burroughs; C.A. Brass; J.K. Albrecht

Book ID: 117377422
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 53 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60415-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

831 FibroTest (Ft) Baseline Value Is An

831 FibroTest (Ft) Baseline Value Is An Independent Predictor of Early (EVR) and Sustained Virological Response (SVR) in Non-Responders Patients Re-Treated with Pegylated Interferon Alfa-2B (PEG-2B) and Ribavirin in EPIC3

✍ Poynard, Thierry; Schiff, Eugene R.; Terg, Ruben; Moreno-Otero, Ricardo; Flamm, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

FibroTest is an independent predictor of

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program

✍ Thierry Poynard; Mona Munteanu; Massimo Colombo; Jordi Bruix; Eugene Schiff; Rub 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Corrigendum to: “FibroTest is an indepen

Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

✍ Poynard, Thierry; Munteanu, Mona; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Utility of Historical Data Compared to L

Utility of Historical Data Compared to Lead-in Response in Predicting Sustained Virologic Response in Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated With Boceprevir+Peginterferon Alfa-2B/Ribavirin (PR)

✍ Esteban, Rafael ;Gordon, Stuart C. ;Lawitz, Eric J. ;Marcellin, Patrick ;Vierlin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

[573] COMPARISON OF EARLY VIROLOGIC RESP

[573] COMPARISON OF EARLY VIROLOGIC RESPONSE AMONG PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE NON 2/3 TREATED WITH PEGYLATED INTERFERON ALFA-2b AND RIBAVIRIN IN DEPENDENCE WITH HEPATIC FIBROSIS STAGES

✍ H. Berak; A. Kolakowska-Rzadzka; M. Wasilewski; J. Kowalska; I. Stanczak; K. Bar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 140 KB

418 UTILITY OF HISTORICAL DATA COMPARED

418 UTILITY OF HISTORICAL DATA COMPARED TO LEAD-IN RESPONSE IN PREDICTING SUSTAINED VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR+PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R)

✍ R. Esteban; S. Gordon; E. Lawitz; P. Marcellin; J. Vierlin; S. Zeuzem; F. Poorda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB